Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-11
DOI
10.1186/s13046-021-02062-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis
- (2019) Anna Bagnato et al. Frontiers in Pharmacology
- Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders
- (2019) Hidetoshi Komatsu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling
- (2019) Guoxu Fang et al. CANCER LETTERS
- Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma
- (2018) Oriana Lo Re et al. HEPATOLOGY
- The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
- (2017) Yuri K. Peterson et al. PHARMACOLOGICAL REVIEWS
- IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1
- (2016) Christiane Koppe et al. HEPATOLOGY
- Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway
- (2015) Bilun Ke et al. DIABETES
- Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
- (2015) Shlomi Finkin et al. NATURE IMMUNOLOGY
- β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling
- (2015) Yidong Yang et al. Nature Communications
- β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells
- (2014) Roberta Cianfrocca et al. LIFE SCIENCES
- A preventable cancer
- (2014) Lucas Laursen NATURE
- Soyasaponins Can Blunt Inflammation by Inhibiting the Reactive Oxygen Species-Mediated Activation of PI3K/Akt/NF-kB Pathway
- (2014) Longying Zha et al. PLoS One
- Identification of a Nuclear Localization Sequence in β-Arrestin-1 and Its Functional Implications
- (2012) Crystal Zoe Hoeppner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
- (2011) S. I. Grivennikov et al. ANNALS OF THE RHEUMATIC DISEASES
- PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice
- (2011) Wei Qiu et al. HEPATOLOGY
- ARRB1-Mediated Regulation of E2F Target Genes in Nicotine-Induced Growth of Lung Tumors
- (2011) Piyali Dasgupta et al. JNCI-Journal of the National Cancer Institute
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
- (2011) Tom Luedde et al. Nature Reviews Gastroenterology & Hepatology
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
- (2010) Nayana Ghosh-Choudhury et al. CELLULAR SIGNALLING
- -Arrestin/Ral Signaling Regulates Lysophosphatidic Acid-Mediated Migration and Invasion of Human Breast Tumor Cells
- (2009) T. T. Li et al. MOLECULAR CANCER RESEARCH
- Contradictory functions of NF-κB in liver physiology and cancer
- (2008) Gilad W. Vainer et al. CANCER LETTERS
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started